Secondary adrenal insufficiency medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
==== '''Secondary adrenal insufficiency''' ==== | ==== '''Secondary adrenal insufficiency''' ==== | ||
* Preferred regimen: [[Hydrocortisone]] 15-25 mg PO q8-12h | * Preferred regimen: [[Hydrocortisone]] 15-25 mg PO q8-12h life time. | ||
==References== | ==References== | ||
Revision as of 13:58, 3 October 2017
|
Adrenal insufficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Secondary adrenal insufficiency medical therapy On the Web |
|
American Roentgen Ray Society Images of Secondary adrenal insufficiency medical therapy |
|
Risk calculators and risk factors for Secondary adrenal insufficiency medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The mainstay of treatment for secondary adrenal insufficiency is treating the underlying cause. For symptomatic cases, hydrocortisone should be administered.
Medical Therapy
- Pharmacologic medical therapies for secondary adrenal insufficiency include Hydrocortisone.
Secondary adrenal insufficiency
- Preferred regimen: Hydrocortisone 15-25 mg PO q8-12h life time.